Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Mar;63(2):191-200.
doi: 10.1007/s10616-011-9341-1. Epub 2011 Mar 19.

3,4,5-tri-O-caffeoylquinic acid inhibits amyloid β-mediated cellular toxicity on SH-SY5Y cells through the upregulation of PGAM1 and G3PDH

Affiliations

3,4,5-tri-O-caffeoylquinic acid inhibits amyloid β-mediated cellular toxicity on SH-SY5Y cells through the upregulation of PGAM1 and G3PDH

Yusaku Miyamae et al. Cytotechnology. 2011 Mar.

Abstract

Caffeoylquinic acid (CQA) is one of the phenylpropanoids found in a variety of natural resources and foods, such as sweet potatoes, propolis, and coffee. Previously, we reported that 3,5-di-O-caffeoylquinic acid (3,5-di-CQA) has a neuroprotective effect against amyloid-β (Aβ)-induced cell death through the overexpression of glycolytic enzyme. Additionally, 3,5-di-CQA administration induced the improvement of spatial learning and memory on senescence accelerated-prone mice (SAMP8). The aim of this study was to investigate whether 3,4,5-tri-O-caffeoylquinic acid (3,4,5-tri-CQA), isolated from propolis, shows a neuroprotective effect against Aβ-induced cell death on human neuroblastoma SH-SY5Y cells. To clarify the possible mechanism, we performed proteomics and real-time RT-PCR as well as a measurement of the intracellular adenosine triphosphate (ATP) level. These results showed that 3,4,5-tri-CQA attenuated the cytotoxicity and prevented Aβ-mediated apoptosis. Glycolytic enzymes, phosphoglycerate mutase 1 (PGAM1) and glyceraldehyde-3-phosphate dehydrogenase (G3PDH) were overexpressed in co-treated cells with both 3,4,5-tri-CQA and Aβ. The mRNA expression of PGAM1, G3PDH, and phosphoglycerate kinase 1 (PGK1), and intracellular ATP level were also increased in 3,4,5-tri-CQA treated cells. Taken together the findings in our study suggests that 3,4,5-tri-CQA shows a neuroprotective effect against Aβ-induced cell death through the upregulation of glycolytic enzyme mRNA as well as ATP production activation.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Structure of 3,4,5-tri-O-caffeoylquinic acid
Fig. 2
Fig. 2
Effect of 3,4,5-tri-CQA on the Aβ1–42 treated SH-SY5Y cells viability. SH-SY5Y cells were treated with 3,4,5-tri-CQA or 10 μM Aβ1–42 (Aβ) for 72 h. Each bar represents the mean ± SD (n = 10). ** p < 0.01 versus control, ## p < 0.01 versus the cells treated only Aβ
Fig. 3
Fig. 3
Two-dimensional gel electrophoresis of SH-SY5Y cells (a), the magnified images of box regions (b). SH-SY5Y cells were treated with 20 μM 3,4,5-tri-CQA or exposed to 10 μM Aβ1–42 for 72 h. The 2-DE gel was stained with coomassie brilliant blue. Spot value was measured by ImageMaster 2D Platinum software
Fig. 4
Fig. 4
Effect of 3,4,5-tri-CQA on the expressions of G3PDH (a), PGAM1 (b), and PGK1 (c) mRNAs by SH-SY5Y cells. β-actin was used as a housekeeping gene. The mRNA expression of PGAM1 and PGK1 was normalized by β-actin mRNA expression. SH-SY5Y cells were treated with 10 μM 3,4,5-tri-CQA for 8 and 16 h. Each bar represents the mean ± SD (n = 4). *0.01 < p < 0.05 versus control cell, **p < 0.01 versus control cell
Fig. 5
Fig. 5
Effect of 3,4,5-tri-CQA on the intracellular ATP production of SH-SY5Y cells. SH-SY5Y cells were treated with 1, 5, and 10 μM 3,4,5-tri-CQA for 48 h. Intracellular ATP production was increased by 3,4,5-tri-CQA treatment on SH-SY5Y cells. Each bar represents the mean ± SD (n = 10). *0.01 < p < 0.05 versus control cell, **p < 0.01 versus control cell
Fig. 6
Fig. 6
DPPH radical scavenging activity of 3,4,5-tri-CQA. Each bar represents the mean ± SD (n = 6) of the inhibition of DPPH radical (% inhibition)

Similar articles

Cited by

References

    1. Atamna H, Frey WHII. Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease. Mitochondrion. 2007;7:297–310. doi: 10.1016/j.mito.2007.06.001. - DOI - PubMed
    1. Boyd-Kimball D, Sultana R, Poon HF, Lynn BC, Casamenti F, Pepeu G, Klein JB, Butterfield DA. Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1–42) into rat brain: implications for Alzheimer’s disease. Neuroscience. 2005;132:313–324. doi: 10.1016/j.neuroscience.2004.12.022. - DOI - PubMed
    1. Butterfield DA, Boyd-Kimball D. The critical role of methionine 35 in Alzheimer’s amyloid beta-peptide (1–42)-induced oxidative stress and neurotoxicity. Biochim Biophys Acta. 2005;1703:149–156. - PubMed
    1. Canback B, Andersson SGE, Kurland CG. The global phylogency of glycolytic enzymes. Proc Natl Acad Sci USA. 2002;99:6097–6102. doi: 10.1073/pnas.082112499. - DOI - PMC - PubMed
    1. Cardoso SM, Santos S, Swerdlow RH, Oliveira CR. Functional mitochondria are required for amyloid beta-mediated neurotoxicity. FASEB J. 2001;15:1439–1441. - PubMed